drugset / Trial / NCT00515294
Acute and Residual Effects of Caffeinated Beer
Phase 1/2
Completed
154 enrolled
Boston University
Brown University · collabCenters for Disease Control and Prevention · collabUniversity of Michigan · collab
RandomizedFactorialTriple-blindOther
Summary
The aim of this study is to develop information about the acute and residual effects of a new product being targeted to young adults. Using a double placebo-controlled 2 X 2 factorial model study design, we will compare the acute and residual effects on driving impairment of caffeinated alcohol, non-caffeinated alcohol, caffeinated placebo, and non-caffeinated placebo. Under the alcohol conditions, participants will receive sufficient alcoholic beverage to attain a blood alcohol concentration (BAC) of .12 g%. Participants will be 144 undergraduate and graduate students, and recent college graduates.
Timeline
- Start
- 2006-10
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | 69 mg | — |